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Abstract
Background: Despite the remarkable technological progress in health care and treatment, cardiovascular disease
remains the leading cause of premature death, prolonged hospitalization and disability in most European countries.
In the population of the Greater Region (Grand-Duchy of Luxembourg, Wallonia in Belgium, and Lorraine in
France), the prevalence of cardiovascular risk factors and disease is among the highest in Europe, warranting the
need for a better understanding of factors contributing to this pattern. In this context, the cross-border “Nutrition,
Environment and Cardiovascular Health-NESCAV” project is initiated by an inter-regional multi-disciplinary
consortium and supported by the INTERREG IV A program “Greater Region”, 2007-2013, to fight synergically and
harmoniously against this major public health problem.
Methods/design: The objectives of the three-year planned project are to assess, in a representative sample of
3000 randomly selected individuals living at the Greater Region, 1) the cardiovascular health and risk profile, 2) the
association between the dietary habits and the cardiovascular risk, 3) the association of occupational and
environmental pollution markers with the cardiovascular risk, 4) the knowledge, awareness and level of control of
cardiovascular risk factors, 5) the potential gaps in the current primary prevention, and finally, to address evidence-
based recommendations enabling the development of inter-regional guidance to help policy-makers and health
care workers for the prevention of cardiovascular disease.
Discussion: The findings will provide tools that may enable the Greater Region’s decision-makers and health
professionals to implement targeted and cost-effective prevention strategies.
Background
Despite the remarkable technological progress in health
care and treatment, cardiovascular disease (CVD)
remains the leading cause of premature death in most
European populations [1]. It accounts for over 4 million
deaths yearly, i.e., nearly half (49%) of all European mor-
tality, but with striking geographical variations [2]. CVD
represents an important source of prolonged hospitaliza-
tion, and disability, contributing therefore to escalate the
costs to health care systems[3].
In the frame of the European inter-regional program,
Interreg III A 2003-2006, covering the Greater Region
located in the heart of Europe, a cross-border study was
carried out to explore the availability of information
regarding the cardiovascular health indicators, such as
the mortality, morbidity, and risk factors among the
population. The study associated three neighbouring
regions; Grand-Duchy of Luxembourg, Wallonia in Bel-
gium, and Lorraine in France. While the cardiovascular
mortality data were merely available for the period of
1987 to 1997, the comparative study revealed a substan-
tial data shortage regarding cardiovascular morbidity
and lifestyle-related risk factors, particularly in Luxem-
bourg and Wallonia. The huge inter-regional discrepan-
cies in the health information systems were not only
related to heterogeneous methods and tools used for
data collection, but also to total absence of data as
regards to important potentially modifiable risk factors,
for instance, dietary habits and physical activity[4].
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and clinical evidence has raised the potential deleterious
effects of air pollution on health and its relation to heart
disease and stroke [5]. An insight about the occupational
and environmental pollution and its relation to cardiovas-
cular risk was almost deficient in the three regions.
The inter-regional information gaps and data inconsis-
tency precluded relevant cardiovascular health indica-
tor’s comparison[4]. From prevention point of view, this
outcome made epidemiological cardiovascular health
monitoring, particularly with regard to dietary and
environmental factors, as one of the major topics for the
Greater Region’s public health authorities.
Cardiovascular disease prevention became a crucial
contemporary public health challenge. The multi-
factorial etiology of cardiovascular disease implies multi-
facetted intervention program, to modify individual
cardiovascular risk factors with diet, exercise, weight
management, complete smoking cessation, and avoid-
ance of environmental pollution [6].
Against this background, the idea of cross-border car-
diovascular health monitoring was born in 2005. The
outline of a standard protocol was conceived by the
inter-regional committee which consisted of partners
from the three regions, with various skills in the fields
of public health, epidemiology, cardiology, nutrition and
environment.
Under the auspices of INTERREG IV A program,
2007-2013, the Public Health Research Centre in Lux-
embourg (CRP-santé) initiated and coordinated the
implementation of a complementary cross-border pro-
ject; entitled “Nutrition, Environment and Cardiovascu-
lar Health NESCAV”. This project includes the same 3
neighbour regions: Grand-Duchy of Luxembourg, Wal-
lonia, Lorraine, in addition to Saarland. Its main goals
are to build up a standard instrument to evaluate cardi-
ovascular health and risk factors profile and to identify
the potential gaps in the current primary prevention
approaches in order to develop effective inter-regional
networks and partnerships for concerted global action
across the Greater Region. The ultimate aim of the
multi-disciplinary NESCAV project is to fight efficiently
against this major public health challenge, presented by
the cardiovascular risk.
Objectives
Within the NESCAV project, and in a representative
sample of the population living in the Greater Region, 6
key objectives are developed: 1) describe and assess the
cardiovascular health and risk profile, 2) explore the asso-
ciation between the dietary habits and the cardiovascular
risk, 3) describe and assess the occupational and environ-
mental pollution markers and examine their association
with the cardiovascular risk, 4) assess the knowledge,
awareness and level of control of cardiovascular risk
factors (Hypertension, diabetes and dyslipidemia), 5)
identify the potential gaps in the current primary preven-
tion in order to improve the existing approaches and
promote cross-border cardiovascular health, and 6)
address evidence-based recommendations enabling the
development of inter-regional guidance to help policy-
makers and health care workers for the prevention of car-
diovascular disease.
Hypotheses
Although the NESCAV study is mainly descriptive,
aimed at generating hypotheses, however, we formulate
the following assumptions. First, there are significant
inter-regional population disparities, with regard to car-
diovascular health and risk profile. Second, the dietary
habits are remarkably different across the population of
the Greater Region, which may explain, in part, the
observed cardiovascular risk discrepancy. Third, the
populations of the Greater Region are exposed to differ-
ent levels of occupational and environmental pollution,
which potentially influence their cardiovascular health
and risk profile. Fourth, the knowledge, perception and
control of cardiovascular risk are varied significantly
across the population living in the Greater Region. Fifth,
the current preventive interventions, carried out in this
Greater Region did not target the real population at
risk. Sixth, the self-declared level of tobacco and alcohol
consumption is significantly lower than the objective
confirmation via biomarkers.
Methods/Design
The three-year planned project, began in 1
st January
2009, comprises three principal phases, each with stand-
alone objectives and working packages (WP) (Figure 1):
I. Asessment of current cardiovascular health and risk
profile
This phase of the project enfolds 3 interrelated WPs
that aim to achieve the first 3 above-mentioned objec-
tives. It plans to carry out, for the fist time in this Eur-
opean zone, a cross-sectional, population-based survey,
by using a standardised method of recruitment, and vali-
dated data collection tools. In line with the step-wise
strategy of the WHO[7], this approach enables a rele-
vant inter-regional comparison, in terms of cardiovascu-
lar health and lifestyle-related risk factors. From a
public health and research perspective, this cross-border
survey is intended to be repeated at regular intervals to
monitor the evolution. The cardiovascular health status
is assessed by means of a self-administered question-
naire, clinical and anthropometric measurements, as
well as by blood, urine and hair examinations. The
potentially modifiable and treatable risk factors include
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activity, hypertension, dyslipidemia, diabetes mellitus,
obesity and environmental pollution. This cross-border
survey attempts to demonstrate the potential contribu-
tion of the demographic, socio-economic, behavioural,
biological and environmental factors to the cardiovascu-
lar risk, in a representative sample of non-institutiona-
lized participants, aged 18-69 years residing in the
Greater Region. The minimal necessary representative
sample size was calculated to 3000 subjects to ensure
statistical power[8] for examining the various cardiovas-
cular risk factors of interest, i.e. to ensure a statistical
precision of at least 2% for the estimation of the preva-
lence of the risk factors at the 95% confidence level.
The distribution of selected subjects in each region is
proportional to their distribution in the source popula-
tion (adult population of 18 to 69 years residents in the
Greater region). Pregnant women, people living in insti-
tutions, subjects outside the age range 18-69 years and
those deceased before recruitment are excluded.
Given the multi-linguistic nature of the population
residing in this zone, notably for the G-D of Luxem-
bourg, the self-administered questionnaire is translated
from French into the three other most used languages;
German, English and Portuguese. To ensure the validity,
the questionnaire is after that backward translated into
French [9].
For field work, survey staffs are trained regionally to
perform the anthropometric measurements and to help
and check the answers with the participants. For each
region, strict control measures are applied to ensure
quality throughout the conduct of the cross-border sur-
vey, namely, sample selection, operational data-collec-
tion, data processing and reporting. Although, subject’s
recruitment and field data collection are organised at
regional level, a centralized databank is constituted to
introduce inter-regional data, with an on-line access to
the 4 partners (Capture system®). The project’s imple-
mentation and conduct is governed by an official agree-
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Figure 1. Overview of NESCAV project structure
ESP-ULG: School of Public Health-University of Liège ; CRP-Santé : Public Health Research Centre ; CIC : Centre of Clinical Investigation ; US: University of Saarland; WP: Work package, 
NESCAV: Nutrition, Environment and Cardiovascular Health; CVR: cardiovascular risk.
Figure 1 Overview of NESCAV project structure. ESP-ULG: School of Public Health-University of Liège; CRP-Santé: Public Health Research
Centre; CIC: Centre of Clinical Investigation; US: University of Saarland; WP: Work package, NESCAV: Nutrition, Environment and Cardiovascular
Health; CVR: cardiovascular risk.
Alkerwi et al. BMC Public Health 2010, 10:698
http://www.biomedcentral.com/1471-2458/10/698
Page 3 of 6First, 2
nd and 3
rd WPs focus on the epidemiological,
nutritional and environmental aspects of the cardiovascu-
lar risk profile, respectively. The food intake frequencies
and eating habits are assessed by a semi-quantitative food
frequency questionnaire (FFQ), developed and adapted to
regional-cultural and linguistic particularities by the Uni-
versity of Liège in Wallonia. The FFQ aims to assess the
dietary intake, by asking the participants to report the
frequency of consumption and portion size of approxi-
mately 134-line items over the last three months. Each
item is defined by a series of foods or beverages which
are categorized into 9 major food groups: starchy food,
fruits, cooked and raw vegetables, meat-poultry-fish-eggs,
prepared dishes, diary products, fats, divers and, drinks
(alcoholic and non-alcoholic). The Participants reported
the frequency of consumption of each food group on the
basis of 6 levels of frequencies, ranging from rarely or
never or <1 time a day to 2 times or more per day. Stan-
dard serving sizes and food models based on a photo-
graphic manual, validated by the SU.VI.MAX study[10],
are provided as a reference for estimation of food con-
sumed portions.
The assessment of cross-border occupational and
environmental pollution and its relationship to cardio-
vascular risk profile is achieved by hair specimens’
examination for specific biomarkers, namely the poly-
cyclic aromatic hydrocarbons (PAHs) and pesticides, in
addition to information collected by the self-adminis-
tered questionnaire, such as the area of residence, type
of job, smoking and alcohol consumption.
To meet the urgent needs of Luxembourg’s public
health authorities, for relevant baseline information
about the population cardiovascular health status, WP 1,
2 &3 were carried out earlier in Luxembourg, under the
auspices of the Ministry of Health and co-financed by
the Ministry of Research. This part of NESCAV project
corresponds to the national study, entitled Cardiovascu-
lar Risk Factors Observation in Luxembourg “ORIS-
CAV-LUX”. Detailed methodology was published
elsewhere[11,12]. The foregoing achievement of this part
helped as a learning example of feasibility for the other
regions. The data collection of this part of NESCAV
project is currently ongoing in the others regions.
II. Assessment of current population knowledge,
perception and control of cardiovascular risk factors
The population knowledge, perception and awareness of
the impact of cardiovascular risk factors on their global
health, are essential components of behavioral changes
and lifestyle modification[13-15]. Likewise, the patient’s
compliance, self-cardiovascular risk management and
the level of therapeutic control contribute to decrease
the burden. The lack of knowledge, misconceptions, and
the poor level of risk factor control are attributed to
ineffective prevention programs and to confusing educa-
tive messages addressed to inappropriate groups of the
population[16]. In order to develop effective strategies,
tackling “high-risk group” or “population-targeted” stra-
tegies, it is crucial to understand how different popula-
tions view and experience cardiovascular health and
diseases [17]. However, little is known about these issues
among the residents of the Greater Region.
This part of the NESCAV project, corresponding to
the 4
th WP, consists of three sub-steps; questionnaire
development, testing-retesting and validation on a sam-
ple of 41 subjects resident in the Greater Region. Simi-
larly, the questionnaire is backward translated into 4
languages and integrated in the general 1
st phase cross-
border population-based NESCAV survey questionnaire.
This part provides a unique opportunity to examine the
knowledge, awareness, perception and self-control of 3
major cardiovascular risk factors-associated pathologies
(diabetes, hypertension and dyslipidemia) among the
general Greater Region’s population. Standard data on
current lifestyles-related cardiovascular risk factor and
their management are crucial, not only to establish an
objective view of the present population’s health status
but also to identify the potential gaps in health care or
primary prevention approaches, hence to set-up specific
target interventions tailored to real needs of the popula-
tion. Given the magnitude of the problem and the finan-
cial burden of CVD, improvements in the quality of
primary prevention will lead to substantial improvement
in health care outcomes [18].
III. Evidence-based recommendations for cardiovascular
prevention and health promotion
It is well-established that a high proportion of CVD can
be prevented and controlled by lifestyle modifications
[19-21]. Several prospective observational studies
showed that cross-cultural health disparities and low
socio-economic position, measured as education level,
income, or occupational class were associated with
increased risk for type 2 diabetes[22] and coronary heart
disease[23,24]. Evidence-based recommendations tai-
lored to target group at risk are therefore fundamental
to fight efficiently against CVD and mortality.
In most of European countries, diverse prevention pro-
grams and health promotion campaigns, aiming to
endorse population and individual healthy lifestyles, were
planned and organized, to various extents. Ideally, this
should be a systematic process following a prior thorough
needs assessment, data analysis and hence objective selec-
tion of prevention goals. A program best suited for target
population is essential to implement credible and sustain-
able prevention. However, evidence-based CVD preven-
tion programs are currently scarce and their impacts or
effectiveness on the population at risk are rarely evaluated.
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rd phase of the NESCAV project
focuses on bridging the gaps potentially identified in the
initial parts of the project. It is composed of two WPs:
WP5 which seeks to spot the current primary preven-
tion approaches and educative messages in each region,
and WP6 which aims to suggest evidence-based recom-
mendations appropriate to Greater Region’sp o p u l a t i o n
n e e d s .I nt h el i g h to ff i n d i n g so b t a i n e df r o mt h ef i r s t4
WP, this final part of the project aims to develop inter-
regional networks and stakeholders’ partnerships for
concerted actions of prevention across the Greater
Region to fight efficiently against cardiovascular disease.
Ethical aspects
The protocol of the first 4 WPs of the study was
approved by the following institutional review boards:
Comité National d’E t h i q u ed eR e c h e r c h e(Grand-Duchy
of Luxembourg), Comité de Protection des Personnes
Est-III (Lorraine), Comité d’Ethique Hospitalo-Facultaire
Universitaire de Liège (Wallonia) and Ethik-Kommission
Ärztekammer des Saarlandes (Saarland).
In each region, an informed written consent form is
handed to each participant at his/her attendance visit, to
be signed prior to inclusion. In Grand-duchy of Luxem-
bourg, alike to the questionnaire, the consent was pro-
vided in 4 languages (French, English, German and
Portuguese).
Discussion
Based on the findings of cross-border NESCAV survey,
it will be possible to establish for the fist time an objec-
tive panorama of cardiovascular health status of the
Greater Region’s population. However, the challenge is
not merely to monitor the cardiovascular risk factors,
but to evaluate the current risk perception and manage-
ment from population’s standpoint, in order to bridge
the knowledge-practice gaps and to suggest evidence-
based recommendations. The findings will enable the
decision-makers and health professionals to implement
effective and target prevention strategies. At medium to
long term, the outcome may have an impact on the glo-
bal health of the Greater Region population, in terms of
prevention and health care policies as well as on the
economy.
Acknowledgement
The cross-border NESCAV project is supported by INTERREG IV A program
“Greater Region”, 2007-2013, which aims to stimulate inter-regional
cooperation. The four regions receive a co-funding from the European
Regional Development Fund (ERDF), in addition to their own or public
health authorities financial support.
The following individuals are part of the NESCAV group, besides the authors
of this study protocol: Sophie Couffignal, Nicolas sauvageot, Agnès
Columeau, David Marcic, Graziella Ambroset, Brice Appenzeller, Helen
Karlson, Jean Beissel, Charles Delagardelle (Grand-Duchy of Luxembourg);
Adelin Albert, Laurence Counet, Isabel Joslet, Catherine Phillipet, Sylvie Streel,
Stephanie Haterte, Anne-Françoise Donneau (Walonia, Belgium); Patrick
Rossignol, Celine Simon, Anne Valentin, Jean-Marc Boivin Carole Barrailhe
(Lorraine, France); Michael Böhm, Angelika Knoll, Janine Poëss (Saarland).
Author details
1Centre de Recherche Public Santé, Centre d’Etudes en Santé, Grand-Duchy
of Luxembourg.
2School of Public Health, University of Liège, Belgium.
3Centre Hospitalier Universitaire, Hypertension Unit, Département des
maladies cardiovasculaires, Nancy, France.
4University of Saarland, Germany.
Authors’ contributions
AA coordinated the 1
st phase of the project for Luxembourg region, drafted
the present manuscript and participates to scientific decisions at
interregional level. M-LL wrote the NESCAV project protocol in collaboration
with the partners, in the light of final report of the previous project
INTERREG III, coordinated the work packages at inter-regional level, and
supervised all the cross-border project process and data analysis of results.
M-LL, MG, FZ, UL are the NESCAV project leaders of Luxembourg, Wallonia,
Lorraine and Saarland, respectively. All authors commented on the design of
the NESCAV protocol and on drafts of the manuscript, and all approved the
final version.
Competing interests
The authors declare that they have no competing interests.
Received: 26 October 2010 Accepted: 15 November 2010
Published: 15 November 2010
References
1. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R,
Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, et al:
European guidelines on cardiovascular disease prevention in clinical
practice: third joint task force of European and other societies on
cardiovascular disease prevention in clinical practice (constituted by
representatives of eight societies and by invited experts). Eur J
Cardiovasc Prev Rehabil 2003, 10(4):S1-S10.
2. Rayner MPS: European cardiovascular disease statistics. 2000.
3. Graham IM: Guidelines on cardiovascular disease prevention in clinical
practice: the European perspective. Curr Opin Cardiol 2005, 20(5):430-439.
4. Report of the inter-regional groupe of work on the Project Pôle de
prévention cardiovasculaire transfrontalier-INTERREG IIIA, Mortalité,
morbidité et facteurs de risque cardiovasculaire en Wallonie, Lorraine,
Luxembourg - Recensement des données existantes, comparaisons et
premières conclusions. 2005.
5. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R,
Mittleman M, Samet J, Smith SC Jr, et al: Air pollution and cardiovascular
disease: a statement for healthcare professionals from the Expert Panel
on Population and Prevention Science of the American Heart
Association. Circulation 2004, 109(21):2655-2671.
6. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA,
Goldstein LB, Greenland P, Grundy SM, et al: AHA Guidelines for Primary
Prevention of Cardiovascular Disease and Stroke: 2002 Update:
Consensus Panel Guide to Comprehensive Risk Reduction for Adult
Patients Without Coronary or Other Atherosclerotic Vascular Diseases.
American Heart Association Science Advisory and Coordinating
Committee. Circulation 2002, 106(3):388-391.
7. Strong K, Bonita R: Rapport SurF1. Surveillance des facteurs de risque liés
aux maladies non transmissibles: état actuel des données mondiales.
Organisation mondiale de la santé; 2003.
8. Lwanga SK, Lemeshow S: Sample Size Determination in Health Studies: A
Practical Manual. 1991.
9. Anand SS, Yusuf S, Vuksan V, Devanesen S, Montague P, Kelemen L,
Bosch J, Sigouin C, Teo KK, Lonn E, et al: The Study of Health Assessment
and Risk in Ethnic groups (SHARE): rationale and design. The SHARE
Investigators. Can J Cardiol 1998, 14(11):1349-1357.
10. Hercberg S, Galan P, Preziosi P, Roussel AM, Arnaud J, Richard MJ, Malvy D,
Paul-Dauphin A, Briancon S, Favier A: Background and rationale behind
the SU.VI.MAX Study, a prevention trial using nutritional doses of a
combination of antioxidant vitamins and minerals to reduce
cardiovascular diseases and cancers. SUpplementation en VItamines et
Mineraux AntioXydants Study. Int J Vitam Nutr Res 1998, 68(1):3-20.
Alkerwi et al. BMC Public Health 2010, 10:698
http://www.biomedcentral.com/1471-2458/10/698
Page 5 of 611. Alkerwi A, Sauvageot N, Donneau AF, Lair ML, Couffignal S, Beissel J,
Delagardelle C, Wagener Y, Albert A, Guillaume M: First nationwide survey
on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-
LUX). BMC Public Health 2010, 10:468.
12. Alkerwi A, Sauvageot N, Couffignal S, Albert A, Lair ML, Guillaume M:
Comparison of participants and non-participants to the ORISCAV-LUX
population-based study on cardiovascular risk factors in Luxembourg.
BMC Med Res Methodol 2010, 10:80.
13. Nash IS, Mosca L, Blumenthal RS, Davidson MH, Smith SC Jr, Pasternak RC:
Contemporary awareness and understanding of cholesterol as a risk
factor: results of an American Heart Association national survey. Archives
of internal medicine 2003, 163(13):1597-1600.
14. Rieder A: Awareness and control of hypertension in Austria. J Hum
Hypertens 2004, 18(8):535-537.
15. Merz CN, Buse JB, Tuncer D, Twillman GB: Physician attitudes and
practices and patient awareness of the cardiovascular complications of
diabetes. Journal of the American College of Cardiology 2002,
40(10):1877-1881.
16. Eckel RH: Preventive cardiology by lifestyle intervention: opportunity
and/or challenge? Presidential address at the 2005 American Heart
Association Scientific Sessions. Circulation 2006, 113(22):2657-2661.
17. Homko CJ, Santamore WP, Zamora L, Shirk G, Gaughan J, Cross R,
Kashem A, Petersen S, Bove AA: Cardiovascular disease knowledge and
risk perception among underserved individuals at increased risk of
cardiovascular disease. J Cardiovasc Nurs 2008, 23(4):332-337.
18. Redberg RF, Benjamin EJ, Bittner V, Braun LT, Goff DC Jr, Havas S,
Labarthe DR, Limacher MC, Lloyd-Jones DM, Mora S, et al: AHA/ACCF
[corrected] 2009 performance measures for primary prevention of
cardiovascular disease in adults: a report of the American College of
Cardiology Foundation/American Heart Association task force on
performance measures (writing committee to develop performance
measures for primary prevention of cardiovascular disease): developed
in collaboration with the American Academy of Family Physicians;
American Association of Cardiovascular and Pulmonary Rehabilitation;
and Preventive Cardiovascular Nurses Association: endorsed by the
American College of Preventive Medicine, American College of Sports
Medicine, and Society for Women’s Health Research. Circulation 2009,
120(13):1296-1336.
19. Cleeman JI, Lenfant C: The National Cholesterol Education Program:
progress and prospects. JAMA 1998, 280(24):2099-2104.
20. Farquhar JW, Fortmann SP, Flora JA, Taylor CB, Haskell WL, Williams PT,
Maccoby N, Wood PD: Effects of communitywide education on
cardiovascular disease risk factors. The Stanford Five-City Project. JAMA
1990, 264(3):359-365.
21. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V,
Gerstein HC, Grundy S, Nesto RW, et al: Primary prevention of
cardiovascular diseases in people with diabetes mellitus: a scientific
statement from the American Heart Association and the American
Diabetes Association. Circulation 2007, 115(1):114-126.
22. Agardh EE, Ahlbom A, Andersson T, Efendic S, Grill V, Hallqvist J,
Ostenson CG: Explanations of socioeconomic differences in excess risk of
type 2 diabetes in Swedish men and women. Diabetes care 2004,
27(3):716-721.
23. Kaplan GA, Keil JE: Socioeconomic factors and cardiovascular disease: a
review of the literature. Circulation 1993, 88(4 Pt 1):1973-1998.
24. Silventoinen K, Pankow J, Jousilahti P, Hu G, Tuomilehto J: Educational
inequalities in the metabolic syndrome and coronary heart disease
among middle-aged men and women. Int J Epidemiol 2005, 34(2):327-334.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2458/10/698/prepub
doi:10.1186/1471-2458-10-698
Cite this article as: Alkerwi et al.: Nutrition, environment and
cardiovascular health (NESCAV): protocol of an inter-regional cross-
sectional study. BMC Public Health 2010 10:698.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Alkerwi et al. BMC Public Health 2010, 10:698
http://www.biomedcentral.com/1471-2458/10/698
Page 6 of 6